Found 2 articles for: "interleukin-31"

  • Off-Label Uses of Nemolizumab: A Narrative Review

    October 2026 | Volume 25 | Issue 10 | Original Article | 956 | Copyright © October 2026

    Background: Nemolizumab, a humanized monoclonal antibody targeting interleukin-31 receptor α (IL-31Rα), is approved for atopic dermatitis (AD) and prurigo nodularis (...
    Read More

  • Atopic Dermatitis Flare Following Initiation of Nemolizumab

    August 2026 | Volume 25 | Issue 8 | Case Reports | 751 | Copyright © August 2026

    Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder marked by intense pruritus and episodic flares. While nemolizumab, an interleukin-31 (IL-31) inhibitor,...
    Read More